Biotechnology at Rochester Institute of Technology

RIT's biotechnology program lands squarely in the middle of New York's offerings—ranking at the 40th percentile statewide—but falls short of national benchmarks. With first-year earnings of $41,895, graduates earn about $5,000 less than the national median for biotech grads, though they're roughly on par with Syracuse's program nearby. The $24,125 debt load is slightly below the state median, creating a manageable debt-to-earnings ratio of 0.58, meaning graduates need about seven months of gross income to cover their loans.

The encouraging sign here is trajectory: earnings jump 37% by year four, reaching $57,558. That's solid income growth in a field where early-career professionals often need time to find their footing. However, the small sample size (under 30 graduates) means these numbers could shift significantly year to year, making them less reliable as predictors than data from larger programs.

For a family considering this program, understand that you're paying for RIT's strong cooperative education model and industry connections, not standout starting salaries. If your student thrives in hands-on learning environments and values career services support, the middling initial earnings may be worth the investment. But if pure salary ROI drives your decision, this program doesn't outperform its in-state competitors enough to justify choosing RIT over alternatives—especially if a less expensive SUNY option offers similar outcomes.